Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils
Carregando...
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2017
Editora
NATURE PUBLISHING GROUP
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
ALVAREZ, Karla Lucia Fernandez
BELDI, Mariana
SARMANHO, Fabiane
ROSSETTI, Renata Ariza Marques
SILVEIRA, Caio Raony Farina
ANDREOLI, Maria Antonieta
CARUSO, Eliana Dias de Carvalho
KAMILLOS, Marcia Ferreira
SOUZA, Ana Marta
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
SCIENTIFIC REPORTS, v.7, article ID 9002, 16p, 2017
Resumo
Cervical cancer is the last stage of a series of molecular and cellular alterations initiated with Human Papillomavirus (HPV) infection. The process involves immune responses and evasion mechanisms, which culminates with tolerance toward tumor antigens. Our objective was to understand local and systemic changes in the interactions between HPV associated cervical lesions and the immune system as lesions progress to cancer. Locally, we observed higher cervical leukocyte infiltrate, reflected by the increase in the frequency of T lymphocytes, neutrophils and M2 macrophages, in cancer patients. We observed a strong negative correlation between the frequency of neutrophils and T cells in precursor and cancer samples, but not cervicitis. In 3D tumor cell cultures, neutrophils inhibited T cell activity, displayed longer viability and longer CD16 expression half-life than neat neutrophil cultures. Systemically, we observed higher plasma G-CSF concentration, higher frequency of immature low density neutrophils, and tolerogenic monocyte derived dendritic cells, MoDCs, also in cancer patients. Interestingly, there was a negative correlation between T cell activation by MoDCs and G-CSF concentration in the plasma. Our results indicate that neutrophils and G-CSF may be part of the immune escape mechanisms triggered by cervical cancer cells, locally and systemically, respectively.
Palavras-chave
Referências
- Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012
- Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2
- Chuang FYS, 2000, J IMMUNOL, V164, P350
- COLEMAN N, 1994, AM J CLIN PATHOL, V102, P768
- de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831
- Deng YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153567
- Eikawa S, 2010, J IMMUNOL, V185, P6734, DOI 10.4049/jimmunol.1000225
- FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543
- Fujimoto H, 2000, CYTOMETRY, V42, P371, DOI 10.1002/1097-0320(20001215)42:6<371::AID-CYTO1004>3.0.CO;2-G
- Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350
- Gordon KM, 2003, J IMMUNOL METHODS, V275, P113, DOI 10.1016/S0022-1759(03)00009-7
- Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
- Hammes LS, 2007, GYNECOL ONCOL, V105, P157, DOI 10.1016/j.ygyno.2006.11.023
- Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889
- Jiang ST, 2016, ONCOL LETT, V12, P2625, DOI 10.3892/ol.2016.5014
- Jordan K. R., 2017, CANC IMMUNO IN PRESS, V66
- Kawano M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18217
- Kerdiles Y, 2013, J EXP MED, V210, P1065, DOI 10.1084/jem.20130960
- Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33
- Koshiol J, 2014, INT J CANCER, V134, P411, DOI 10.1002/ijc.28354
- Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489
- Mabuchi S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju147
- Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037
- Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660
- Maqbool M., 1994, MED J MALAYSIA, V66, P296
- Marini O., 2017, BLOOD IN PRESS
- Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095
- MULDER WMC, 1994, CANCER IMMUNOL IMMUN, V38, P253, DOI 10.1007/s002620050061
- Palefsky Joel M, 2003, J Natl Cancer Inst Monogr, P41
- Perobelli SM, 2016, J IMMUNOL, V197, P3725, DOI 10.4049/jimmunol.1502023
- Petrillo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136654
- Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388
- Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990
- Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984539
- Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836
- Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039
- Sauce D, 2017, J GERONTOL A-BIOL, V72, P163, DOI 10.1093/gerona/glw062
- Stone SC, 2014, IMMUN INFLAMM DIS, V2, P63, DOI 10.1002/iid3.21
- Stone SC, 2014, J LEUKOCYTE BIOL, V96, P619, DOI 10.1189/jlb.3A0513-282R
- Trimble CL, 2010, J IMMUNOL, V185, P7107, DOI 10.4049/jimmunol.1002756
- van der Burg SH, 2007, P NATL ACAD SCI USA, V104, P12087, DOI 10.1073/pnas.0704672104
- Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U
- Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
- Wu JY, 2017, ONCOTARGET, V8, P13400, DOI 10.18632/oncotarget.14541
- Zhang H, 2015, GASTRIC CANCER, V18, P740, DOI 10.1007/s10120-014-0422-7
Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/24
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/24